CALGARY WEATHER

Calgary’s Syantra Teams Up to Take on Breast Cancer Detection – Here’s What It Means for You

Calgary’s biotech scene is buzzing! Local innovator Syantra announced on November 3, 2025, a groundbreaking partnership with the Alamo Breast Cancer Foundation, aiming to revolutionize breast cancer detection and bring more inclusive care. This collaboration marries cutting-edge science with robust advocacy, a critical step as Calgary continues to solidify its reputation as a burgeoning biotech hub, home to over 120 life sciences companies.

Syantra’s Onco-ID Breast test promises faster, more accessible early cancer detection, particularly vital for women with dense breast tissue, a factor affecting over 43% of women aged 40 or older. This initiative, supported by Alberta Innovates, expands clinical studies and boosts cancer awareness, directly addressing access challenges for underrepresented communities. Syantra CEO Rob Lozuk hails it as a "first-of-its-kind" collaboration.

The impact right here in Calgary is significant, potentially leading to earlier diagnoses and improved treatment pathways for our community. Syantra's deep local roots are further exemplified by co-founder Kristina Rinker, who is a founding partner of Biohubx, a new lab facility in northwest Calgary dedicated to nurturing early-stage life science ventures. This partnership underscores how local research, driven by innovative minds and supported by organizations like Alberta Innovates, is contributing to global health solutions directly from our backyard.